These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

146 related articles for article (PubMed ID: 16479829)

  • 1. [A long term survival of the patient treated due to advanced adrenocortical carcinoma].
    Bednarek-Tupikowska G; Florczak A; Witkiewicz W; Tupikowski W; Cisarz E
    Pol Arch Med Wewn; 2005 May; 113(5):462-5. PubMed ID: 16479829
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Surgical management of adrenocortical carcinoma.
    Ranvier GG; Inabnet WB
    Endocrinol Metab Clin North Am; 2015 Jun; 44(2):435-52. PubMed ID: 26038210
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Adjuvant mitotane in adrenocortical carcinoma.
    Bertherat J; Coste J; Bertagna X
    N Engl J Med; 2007 Sep; 357(12):1256-7; author reply 1259. PubMed ID: 17881760
    [No Abstract]   [Full Text] [Related]  

  • 4. Is there a role for low doses of mitotane (o,p'-DDD) as adjuvant therapy in adrenocortical carcinoma?
    Dickstein G; Shechner C; Arad E; Best LA; Nativ O
    J Clin Endocrinol Metab; 1998 Sep; 83(9):3100-3. PubMed ID: 9745410
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Adrenocortical carcinoma: surgery and mitotane for treatment and steroid profiles for follow-up.
    Khorram-Manesh A; Ahlman H; Jansson S; Wängberg B; Nilsson O; Jakobsson CE; Eliasson B; Lindstedt S; Tisell LE
    World J Surg; 1998 Jun; 22(6):605-11; discussion 611-2. PubMed ID: 9597936
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Percutaneous laser ablation of unresectable primary and metastatic adrenocortical carcinoma.
    Pacella CM; Stasi R; Bizzarri G; Pacella S; Graziano FM; Guglielmi R; Papini E
    Eur J Radiol; 2008 Apr; 66(1):88-94. PubMed ID: 17498906
    [TBL] [Abstract][Full Text] [Related]  

  • 7. [Normalisation of contralateral adrenal function after long-term mitotane therapy in a girl after surgical treatment of adrenocortical carcinoma].
    Lecka A; Ginalska-Malinowska M
    Endokrynol Diabetol Chor Przemiany Materii Wieku Rozw; 2006; 12(3):234-6. PubMed ID: 17020662
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Treatment of metastatic adrenal cortical carcinoma with etoposide (VP-16) and cisplatin after failure with o,p'DDD. Clinical case reports.
    Zidan J; Shpendler M; Robinson E
    Am J Clin Oncol; 1996 Jun; 19(3):229-31. PubMed ID: 8638530
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Long-term (15 years) outcome in an infant with metastatic adrenocortical carcinoma.
    De León DD; Lange BJ; Walterhouse D; Moshang T
    J Clin Endocrinol Metab; 2002 Oct; 87(10):4452-6. PubMed ID: 12364417
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Long-term complete remission of metastatic adrenocortical carcinoma.
    Cárdenas-Salas J; Castelo B; Regojo RM; González-Sanchez JA; Álvarez-Escolá C
    Horm Mol Biol Clin Investig; 2023 Mar; 44(1):67-71. PubMed ID: 36069780
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Adjuvant mitotane in adrenocortical carcinoma.
    Dickstein G; Shechner C; Nativ O
    N Engl J Med; 2007 Sep; 357(12):1257-8; author reply 1259. PubMed ID: 17891838
    [No Abstract]   [Full Text] [Related]  

  • 12. Adjuvant mitotane in adrenocortical carcinoma.
    Lee JE
    N Engl J Med; 2007 Sep; 357(12):1258; author reply 1259. PubMed ID: 17891836
    [No Abstract]   [Full Text] [Related]  

  • 13. [Mitotane treatment in a dog with a recurring adrenocortical carcinoma--a case report].
    Keiser M; Flückiger M; Gardelle O; Reusch C
    Schweiz Arch Tierheilkd; 1999; 141(6):279-85. PubMed ID: 10389485
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Adjuvant mitotane therapy of adrenal cancer - use and controversy.
    Schteingart DE
    N Engl J Med; 2007 Jun; 356(23):2415-8. PubMed ID: 17554125
    [No Abstract]   [Full Text] [Related]  

  • 15. Mitotane treatment for adrenocortical carcinoma: an overview.
    De Francia S; Ardito A; Daffara F; Zaggia B; Germano A; Berruti A; Di Carlo F
    Minerva Endocrinol; 2012 Mar; 37(1):9-23. PubMed ID: 22382612
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Metastatic congenital adrenocortical carcinoma: a case report with tumor remission at 3 1/2 years.
    Godil MA; Atlas MP; Parker RI; Priebe CJ; Zerah MM; Kane P; Tsung J; Wilson TA
    J Clin Endocrinol Metab; 2000 Nov; 85(11):3964-7. PubMed ID: 11095414
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Metastatic adrenocortical carcinoma with a prolonged response to mitotane.
    Pal SK; Gartrell B; Olsson CA; Stein CA
    Oncology (Williston Park); 2014 Jul; 28(7):624-5, 642. PubMed ID: 25144285
    [No Abstract]   [Full Text] [Related]  

  • 18. Adjuvant mitotane for adrenocortical cancer--working through uncertainty.
    Terzolo M; Fassnacht M; Ciccone G; Allolio B; Berruti A
    J Clin Endocrinol Metab; 2009 Jun; 94(6):1879-80. PubMed ID: 19494162
    [No Abstract]   [Full Text] [Related]  

  • 19. Adjuvant mitotane treatment for adrenocortical carcinoma.
    Terzolo M; Angeli A; Fassnacht M; Daffara F; Tauchmanova L; Conton PA; Rossetto R; Buci L; Sperone P; Grossrubatscher E; Reimondo G; Bollito E; Papotti M; Saeger W; Hahner S; Koschker AC; Arvat E; Ambrosi B; Loli P; Lombardi G; Mannelli M; Bruzzi P; Mantero F; Allolio B; Dogliotti L; Berruti A
    N Engl J Med; 2007 Jun; 356(23):2372-80. PubMed ID: 17554118
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Adjuvant mitotane for adrenocortical cancer--a recurring controversy.
    Huang H; Fojo T
    J Clin Endocrinol Metab; 2008 Oct; 93(10):3730-2. PubMed ID: 18842984
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 8.